Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 82

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 82
---
the “ Surviving LLC”) and will become an indirect subsidiary of Clearwater. At the LLC Merger Effective Time:

| • |     | the issued and outstanding Enfusion Common Units will be converted into the right to receive the Merger                     
 Consideration and the Additional Unit Consideration (as defined in the TRA Amendment) (except as otherwise provided below); |

| • |     | Enfusion Common Units held in the treasury of Enfusion OpCo and any Enfusion Common Units owned by Enfusion,                            
 Clearwater, Enfusion US 1, Inc., Enfusion US 2, Inc., Enfusion US 3, Inc. and any other subsidiary of Enfusion will remain outstanding; |

| • |     | Enfusion Common Units owned by Acquirer, Merger Sub or Merger Sub II will automatically be cancelled and cease to 
 exist; and                                                                                                        |

| • |     | each unit of limited liability company interests of Merger Sub II will automatically be converted into and become                                           
 one unit of limited liability company interests of the Surviving LLC and will constitute the only limited liability company interests of the Surviving LLC. |

Set forth below is a diagram depicting the structure of the LLC Merger. 52

LLC Merger Merger Immediately after the LLC Merger Effective Time, Merger Sub will merge with and into Enfusion, with Enfusion surviving the Merger and becoming a direct, wholly-owned subsidiary of Clearwater. At the Effective Time:

| • |     | the issued and outstanding Enfusion Common Stock will be converted into the right to receive the Merger 
 Consideration (except as otherwise provided below);                                                     |

| • |     | each restricted stock unit of Enfusion that is vested as of immediately prior to the Effective Time or that vests                                      
 in accordance with its terms as a result of the consummation of the Transactions will be converted into the right to receive the Merger Consideration; |

| • |     | the issued and outstanding shares of Enfusion Class B Common Stock will be automatically canceled and will 
 cease to exist;                                                                                            |

| • |     | Enfusion Common Stock and Enfusion Class B Common Stock held in the treasury of Enfusion and any shares of                                                                                                   
 Enfusion Common Stock and Enfusion Class B Common Stock owned by Clearwater, Merger Sub or Merger Sub II immediately prior to the Effective Time will automatically be canceled and will cease to exist; and |

| • |     | each issued and outstanding share of common stock of